Midtrimester abortion produced by intra-amniotic prostaglandin F2α augmented with intravenous oxytoxin
- 1 October 1972
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 114 (4) , 516-519
- https://doi.org/10.1016/0002-9378(72)90213-x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Therapeutic abortion with the use of prostaglandin F2αAmerican Journal of Obstetrics and Gynecology, 1972
- Induction of abortion by intra-amniotic administration of prostaglandin F2αContraception, 1971
- THERAPEUTIC ABORTION AND INDUCTION OF LABOUR BY THE INTRAVAGINAL ADMINISTRATION OF PROSTAGLANDINS E2 AND F2αBJOG: An International Journal of Obstetrics and Gynaecology, 1971
- EFFECTS OF ORAL ADMINISTRATION OF PROSTAGLANDINS E2 AND F2α ON THE HUMAN UTERUSBJOG: An International Journal of Obstetrics and Gynaecology, 1971
- Therapeutic Abortion by Intrauterine Instillation of ProstaglandinsBMJ, 1971
- THE EFFECTS OF PROSTAGLANDINS E2 AND F2α ADMINISTERED BY DIFFERENT ROUTES ON UTERINE ACTIVITY AND THE CARDIOVASCULAR SYSTEM IN PREGNANT AND NON‐PREGNANT WOMENBJOG: An International Journal of Obstetrics and Gynaecology, 1971
- Saline versus glucose as a hypertonic solution for abortionAmerican Journal of Obstetrics and Gynecology, 1970
- The effect of the prostaglandin F compounds on the contractility of the pregnant human uterusAmerican Journal of Obstetrics and Gynecology, 1970
- THERAPEUTIC ABORTION USING PROSTAGLANDIN F2αThe Lancet, 1970
- Effect of Intravenous Administration of Prostaglandin E1 and F2α on the Contractility of the Non‐Pregnant Human Uterus in VivoActa Obstetricia et Gynecologica Scandinavica, 1970